Resveratrol protects rats from Aβ-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Huang, Tai Chun ^a,b   Lu, Kwok Tung ^b   Wo, Yu Yuan Peter ^a   Wu, Yao Ju ^b   Yang, Yi Ling ^a  

^a NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; PHYTOESTROGEN; RESVERATROL; NEUROTOXIN; PROTECTIVE AGENT; STILBENE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CONTROLLED STUDY; DOWN REGULATION; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MAZE TEST; MEMORY DISORDER; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; ROTAROD TEST; SPATIAL MEMORY; ANIMAL; DRUG EFFECT; ENZYMOLOGY; MEMORY; METABOLISM; PATHOLOGY; REACTION TIME; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

AMYLOID BETA-PEPTIDES; ANIMALS; HEME OXYGENASE-1; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MAZE LEARNING; MEMORY; NEURONS; NEUROTOXINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE II; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; ROTAROD PERFORMANCE TEST; STILBENES;

EID: 84855283935     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029102     Document Type: Article

References (55)

1. van Marum RJ, (2008) Current and future therapy in Alzheimer's disease. Fundam Clin Pharmacol 22: 265-274.
2. Wimo A, Winblad B, Aguero-Torres H, von Strauss E, (2003) The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord 17: 63-67.
3. Roberson ED, Mucke L, (2006) 100 years and counting: prospects for defeating Alzheimer's disease. Science 314: 781-784.
4. Kim J, Lee HJ, Lee KW, (2010) Naturally occurring phytochemicals for the prevention of Alzheimer's disease. J Neurochem 112: 1415-1430.
5. Su B, Wang X, Nunomura A, Moreira PI, Lee HG, et al. (2008) Oxidative stress signaling in Alzheimer's disease. Curr Alzheimer Res 5: 525-532.
6. Pacher P, Beckman JS, Liaudet L, (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424.
7. Schopfer FJ, Baker PR, Freeman BA, (2003) NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response? Trends Biochem Sci 28: 646-654.
8. Wang Q, Rowan MJ, Anwyl R, (2004) Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide. J Neurosci 24: 6049-6056.
9. Chen RS, Wu PL, Chiou RY, (2002) Peanut roots as a source of resveratrol. J Agric Food Chem 50: 1665-1667.
10. Soleas GJ, Diamandis EP, Goldberg DM, (1997) Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 11: 287-313.
11. Lu KT, Chiou RY, Chen LG, Chen MH, Tseng WT, et al. (2006) Neuroprotective effects of resveratrol on cerebral ischemia-induced neuron loss mediated by free radical scavenging and cerebral blood flow elevation. J Agric Food Chem 54: 3126-3131.
12. Marambaud P, Zhao H, Davies P, (2005) Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 280: 37377-37382.
13. Lu KT, Ko MC, Chen BY, Huang JC, Hsieh CW, et al. (2008) Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem 56: 6910-6913.
14. Klinge CM, Wickramasinghe NS, Ivanova MM, Dougherty SM, (2008) Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J 22: 2185-2197.
15. Li H, Forstermann U, (2009) Resveratrol: a multifunctional compound improving endothelial function. Editorial to: "Resveratrol supplementation gender independently improves endothelial reactivity and suppresses superoxide production in healthy rats" by S. Soylemez et al. Cardiovasc Drugs Ther 23: 425-429.
16. Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, et al. (2005) SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 280: 40364-40374.
17. Ewing JF, Maines MD, (2006) Regulation and expression of heme oxygenase enzymes in aged-rat brain: age related depression in HO-1 and HO-2 expression and altered stress-response. J Neural Transm 113: 439-454.
18. Willis D, Moore AR, Frederick R, Willoughby DA, (1996) Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med 2: 87-90.
19. Baranano DE, Snyder SH, (2001) Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc Natl Acad Sci U S A 98: 10996-11002.
20. Motterlini R, Foresti R, Bassi R, Calabrese V, Clark JE, et al. (2000) Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and S-nitrosothiols. J Biol Chem 275: 13613-13620.
21. Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ, (1997) Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 100: 1209-1216.
22. Yet SF, Layne MD, Liu X, Chen YH, Ith B, et al. (2003) Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 17: 1759-1761.
23. Chen K, Gunter K, Maines MD, (2000) Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem 75: 304-313.
24. Hung SY, Liou HC, Kang KH, Wu RM, Wen CC, et al. (2008) Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity. Mol Pharmacol 74: 1564-1575.
25. Le WD, Xie WJ, Appel SH, (1999) Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury. J Neurosci Res 56: 652-658.
26. Schipper HM, Song W, Zukor H, Hascalovici JR, Zeligman D, (2009) Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem 110: 469-485.
27. Chen CY, Jang JH, Li MH, Surh YJ, (2005) Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun 331: 993-1000.
28. Cerny D, Canova NK, Martinek J, Horinek A, Kmonickova E, et al. (2009) Effects of resveratrol pretreatment on tert-butylhydroperoxide induced hepatocyte toxicity in immobilized perifused hepatocytes: involvement of inducible nitric oxide synthase and hemoxygenase-1. Nitric Oxide 20: 1-8.
29. Butterfield DA, Boyd-Kimball D, (2005) The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity. Biochim Biophys Acta 1703: 149-56.
30. Stepanichev MY, Zdobnova IM, Zarubenko II, Lazareva NA, Gulyaeva NV, (2006) Studies of the effects of central administration of beta-amyloid peptide (25-35): pathomorphological changes in the hippocampus and impairment of spatial memory. Neurosci Behav Physiol 36: 101-6.
31. Cheng G, Whitehead SN, Hachinski V, Cechetto DF, (2006) Effects of pyrrolidine dithiocarbamate on beta-amyloid (25-35)-induced inflammatory responses and memory deficits in the rat. Neurobiol Dis 23: 140-151.
32. Diaz A, Mendieta L, Zenteno E, Guevara J, Limon ID, (2011) The role of NOS in the impairment of spatial memory and damaged neurons in rats injected with amyloid beta 25-35 into the temporal cortex. Pharmacol Biochem Behav 98: 67-75.
33. Liu RT, Zou LB, Fu JY, Lu QJ, (2010) Effects of liquiritigenin treatment on the learning and memory deficits induced by amyloid β-peptide (25-35) in rats. Behavioural Brain Research 210: 24-31.
34. Morris R, (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47-60.
35. Lu KT, Cheng NC, Wu CY, Yang YL, (2008) NKCC1-mediated traumatic brain injury-induced brain edema and neuron death via Raf/MEK/MAPK cascade. Crit Care Med 36: 917-922.
36. Tillerson JL, Caudle WM, Reveron ME, Miller GW, (2002) Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Exp Neurol 178: 80-90.
37. Li J, Wang C, Zhang JH, Cai JM, Cao YP, et al. (2010) Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress. Brain Res 1328: 152-161.
38. Kim TI, Lee YK, Park SG, Choi IS, Ban JO, et al. (2009) l-Theanine, an amino acid in green tea, attenuates beta-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-kappaB pathways. Free Radic Biol Med 47: 1601-1610.
39. Lee CL, Kuo TF, Wang JJ, Pan TM, (2007) Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid beta-infused rat by repressing amyloid beta accumulation. J Neurosci Res 85: 3171-3182.
40. Lee CL, Pan TM, (2011) Red mold fermented products and Alzheimer's disease: a review. Appl Microbiol Biotechnol 91: 461-469.
41. Duncan AJ, Heales SJ, (2005) Nitric oxide and neurological disorders. Mol Aspects Med 26: 67-96.
42. Seyidova D, Aliyev A, Rzayev N, Obrenovich M, Lamb BT, et al. (2004) The role of nitric oxide in the pathogenesis of brain lesions during the development of Alzheimer's disease. In Vivo 18: 325-333.
43. Kim YA, Lim SY, Rhee SH, Park KY, Kim CH, et al. (2006) Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells. Int J Mol Med 17: 1069-1075.
44. Xie QW, Kashiwabara Y, Nathan C, (1994) Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269: 4705-4708.
45. Terai K, Matsuo A, McGeer PL, (1996) Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Res 735: 159-168.
46. Akama KT, Van Eldik LJ, (2000) Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism. J Biol Chem 275: 7918-7924.
47. Lukiw WJ, Zhao Y, Cui JG, (2008) An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 283: 31315-31322.
48. Schipper HM, Cisse S, Stopa EG, (1995) Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol 37: 758-768.
49. Schipper HM, Bennett DA, Liberman A, Bienias JL, Schneider JA, et al. (2006) Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging 27: 252-61.
50. Schipper HM, (2011) Heme oxygenase-1 in Alzheimer disease: a tribute to Moussa Youdim. J Neural Transm 118: 381-387.
51. Hui Y, Wang D, Li W, Zhang L, Jin J, et al. (2011) Long-Term Overexpression of Heme Oxygenase 1 Promotes Tau Aggregation in Mouse Brain by Inducing Tau Phosphorylation. J Alzheimers Dis 26 (2): 299-313.
52. Pappolla MA, Chyan YJ, Omar RA, Hsiao K, Perry G, et al. (1998) Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol 152: 871-877.
53. Butterfield DA, Barone E, Di Domenico F, Cenini G, Sultana R, et al. (2011) Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain. Int J Neuropsychopharmacol pp. 1-7.
54. Loh KP, Huang SH, De Silva R, Tan BK, Zhu YZ, (2006) Oxidative stress: apoptosis in neuronal injury. Curr Alzheimer Res 3: 327-337.
55. Rottkamp CA, Nunomura A, Raina AK, Sayre LM, Perry G, et al. (2000) Oxidative stress, antioxidants, and Alzheimer disease. Alzheimer Dis Assoc Disord 14 (Suppl 1): S62-66.